CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 158 filers reported holding CLOVIS ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $103,000 | -53.6% | 85,900 | -30.4% | 0.00% | – |
| Q2 2022 | $222,000 | -36.4% | 123,450 | -28.6% | 0.00% | – |
| Q1 2022 | $349,000 | -19.4% | 172,940 | +8.2% | 0.00% | – |
| Q4 2021 | $433,000 | -2.9% | 159,840 | +59.8% | 0.00% | – |
| Q3 2021 | $446,000 | -0.7% | 100,040 | +29.3% | 0.00% | – |
| Q2 2021 | $449,000 | -21.9% | 77,394 | -5.5% | 0.00% | – |
| Q1 2021 | $575,000 | +63.4% | 81,890 | +11.7% | 0.00% | – |
| Q4 2020 | $352,000 | +2.6% | 73,286 | +24.5% | 0.00% | – |
| Q3 2020 | $343,000 | -22.2% | 58,863 | -9.8% | 0.00% | – |
| Q2 2020 | $441,000 | -10.4% | 65,267 | -15.6% | 0.00% | – |
| Q1 2020 | $492,000 | -44.8% | 77,342 | -9.5% | 0.00% | – |
| Q4 2019 | $891,000 | +343.3% | 85,427 | +67.0% | 0.00% | – |
| Q3 2019 | $201,000 | -54.5% | 51,141 | +72.0% | 0.00% | – |
| Q2 2019 | $442,000 | -39.7% | 29,725 | +0.6% | 0.00% | – |
| Q1 2019 | $733,000 | +55.0% | 29,543 | +12.1% | 0.00% | – |
| Q4 2018 | $473,000 | -91.1% | 26,343 | -85.5% | 0.00% | -100.0% |
| Q3 2018 | $5,319,000 | -63.1% | 181,088 | -42.8% | 0.00% | -50.0% |
| Q2 2018 | $14,406,000 | -19.9% | 316,832 | -7.0% | 0.00% | -33.3% |
| Q1 2018 | $17,987,000 | -70.1% | 340,671 | -61.5% | 0.00% | -70.0% |
| Q4 2017 | $60,110,000 | -46.1% | 883,977 | -34.7% | 0.01% | -47.4% |
| Q3 2017 | $111,463,000 | -41.5% | 1,352,705 | -33.5% | 0.02% | -44.1% |
| Q2 2017 | $190,374,000 | +992.8% | 2,033,263 | +643.1% | 0.03% | +1033.3% |
| Q1 2017 | $17,421,000 | -10.7% | 273,618 | -37.7% | 0.00% | -25.0% |
| Q4 2016 | $19,518,000 | -57.8% | 439,406 | -65.7% | 0.00% | -55.6% |
| Q3 2016 | $46,245,000 | +121.6% | 1,282,794 | -15.6% | 0.01% | +125.0% |
| Q2 2016 | $20,865,000 | -30.5% | 1,520,794 | -2.8% | 0.00% | -33.3% |
| Q1 2016 | $30,040,000 | -45.8% | 1,564,605 | -1.2% | 0.01% | -50.0% |
| Q4 2015 | $55,401,000 | -68.9% | 1,582,895 | -18.3% | 0.01% | -70.0% |
| Q3 2015 | $178,115,000 | -8.9% | 1,936,873 | -13.0% | 0.04% | 0.0% |
| Q2 2015 | $195,589,000 | +15.8% | 2,225,637 | -2.2% | 0.04% | +14.3% |
| Q1 2015 | $168,909,000 | +36.3% | 2,275,482 | +2.8% | 0.04% | +34.6% |
| Q4 2014 | $123,951,000 | +115.5% | 2,213,404 | +74.5% | 0.03% | +100.0% |
| Q3 2014 | $57,528,000 | +6.6% | 1,268,251 | -2.7% | 0.01% | +8.3% |
| Q2 2014 | $53,959,000 | -27.7% | 1,303,051 | +21.0% | 0.01% | -29.4% |
| Q1 2014 | $74,606,000 | -32.1% | 1,077,026 | -40.9% | 0.02% | +30.8% |
| Q4 2013 | $109,916,000 | +145.5% | 1,823,710 | +147.6% | 0.01% | +18.2% |
| Q3 2013 | $44,768,000 | -62.3% | 736,555 | -58.4% | 0.01% | -31.2% |
| Q2 2013 | $118,614,000 | – | 1,770,886 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |